Skip to main content

Advertisement

Log in

Significance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren’s Syndrome Patients, in Salivary Duct Epithelial Cells

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The regenerating gene, Reg, was originally isolated from a rat regenerating islet complementary DNA (cDNA) library, and its human homologue was named REG Iα. Recently, we reported that REG Iα messenger RNA (mRNA), as well as its product, was overexpressed in ductal epithelial cells in the salivary glands of Sjögren’s syndrome patients. Furthermore, autoantibodies against REG Iα were found in the sera of Sjögren’s syndrome patients, and the patients who were positive for the anti-REG Iα antibody showed significantly lower saliva secretion than antibody-negative patients. We found the mechanism of REG Iα induction in salivary ductal epithelial cells. Reporter plasmid containing REG Iα promoter (−1190/+26) upstream of a luciferase gene was introduced into human NS-SV-DC and rat A5 salivary ductal cells. The cells were treated with several cytokines (interleukin (IL)-6, IL-8, etc.), upregulated in Sjögren’s syndrome salivary ducts, and the transcriptional activity was measured. IL-6 stimulation significantly enhanced the REG Iα promoter activity in both cells. Deletion analysis revealed that the −141∼−117 region of the REG Iα gene was responsible for the promoter activation by IL-6, which contains a consensus sequence for signal transducer and activator of transcription (STAT) binding. The introduction of small interfering RNA for human STAT3 abolished IL-6-induced REG Iα transcription. These results indicated that IL-6 stimulation induced REG Iα transcription through STAT3 activation and binding to the REG Iα promoter in salivary ductal cells. This dependence of REG Iα induction upon IL-6/STAT in salivary duct epithelial cells may play an important role in the pathogenesis/progression of Sjögren’s syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Pedersen AM, Bardow A, Jensen SB, Nauntofte B (2002) Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 8:117–129

    Article  CAS  PubMed  Google Scholar 

  2. Atkinson JC, Grisius M, Massey W (2005) Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am 49:309–326

    Article  PubMed  Google Scholar 

  3. Fox PC (1998) Acquired salivary dysfunction. Drugs and radiation. Ann NY Acad Sci 842:132–137

    Article  CAS  PubMed  Google Scholar 

  4. Brito-Zerón P, Sisó-Almirall A, Bové A, Kostov BA, Ramos-Casals M (2013) Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. Expert Opin Pharmacother 14:279–289

    Article  PubMed  CAS  Google Scholar 

  5. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010) Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiad Oncol Biol Phys 78:983–991

    Article  Google Scholar 

  6. Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, Visser WH, Kampinga HH, de Haan G, Coppes RP (2008) Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One 3:e2063

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Ogawa M, Oshima M, Imamura A, Sekine Y, Ishida K, Yamashita K, Nakajima K, Hirayama M, Tachikawa T, Tsuji T (2013) Functional salivary gland regeneration by transplantation of a bioengineered organ germ. Nat Commun 4:2498

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Roescher N, Tak PP, Illei GG (2010) Cytokines in Sjögren’s syndrome: potential therapeutic targets. Ann Rheum Dis 69:945–948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y (2013) Novel aspects of Sjögren’s syndrome in 2012. BMC Med 11:93

    Article  PubMed  PubMed Central  Google Scholar 

  10. Roescher N, Tak PP, Illei GG (2009) Cytokines in Sjögren’s syndrome. Oral Dis 15:519–526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nikolov NP, Illei GG (2009) Pathogenesis of Sjögren’s syndrome. Curr Opin Rheumatol 21:465–470

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mariette X, Gottenberg JE (2010) Pathogenesis of Sjögren’s syndrome and therapeutic consequences. Curr Opin Rheumatol 22:471–477

    Article  CAS  PubMed  Google Scholar 

  13. Cornec D, Saraux A, Jousse-Joulin S, Pers JO, Boisramé-Gastrin S, Renaudineau Y, Gauvin Y, Roguedas-Contios AM, Genestet S, Chastaing M, Cochener B, Devauchelle-Pensec V (2015) The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol 49:278–87

    Article  PubMed  Google Scholar 

  14. Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y (2012) Clinical and pathological roles of Ro/SSA autoantibody system. Clin Dev Immunol 2012:606195

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM (2006) Wound healing: immunological aspects. Injury 37(Suppl 1):S5–S12

    Article  PubMed  Google Scholar 

  16. Yonemura Y, Takashima T, Miwa K, Miyazaki I, Yamamoto H, Okamoto H (1984) Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration. Diabetes 33:401–404

    Article  CAS  PubMed  Google Scholar 

  17. Lampeter EF, Gurniak M, Brocker U, Klemens C, Tubes M, Friemann J, Kolb H (1995) Regeneration of beta-cells in response to islet inflammation. Exp Clin Endocrinol Diabetes 103(Suppl 2):74–78

    Article  PubMed  Google Scholar 

  18. Akiyama T, Takasawa S, Nata K, Kobayashi S, Abe M, Shervani NJ, Ikeda T, Nakagawa K, Unno M, Matsuno S, Okamoto H (2001) Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc Natl Acad Sci USA 98:48–53

    CAS  PubMed  Google Scholar 

  19. Rosenberg L (1998) Induction of islet cell neogenesis in the adult pancreas: the partial duct obstruction model. Microsc Res Tech 43:337–346

    Article  CAS  PubMed  Google Scholar 

  20. Hao E, Lee SH, Levine F (2013) Efficient β-cell regeneration by a combination of neogenesis and replication following β-cell ablation and reversal of pancreatic duct ligation. Stem Cells 31:2388–2395

    Article  CAS  PubMed  Google Scholar 

  21. De Breuck S, Baeyens L, Bouwens L (2006) Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas. Diabetologia 49:108–116

    Article  PubMed  CAS  Google Scholar 

  22. Walker NI, Gobé GC (1987) Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J Pathol 153:333–344

    Article  CAS  PubMed  Google Scholar 

  23. Takahashi S, Nakamura S, Suzuki R, Islam N, Domon T, Yamamoto T, Wakita M (2000) Apoptosis and mitosis of parenchymal cells in the duct-ligated rat submandibular gland. Tissue Cell 32:457–463

    Article  CAS  PubMed  Google Scholar 

  24. Hisatomi Y, Okumura K, Nakamura K, Matsumoto S, Satoh A, Nagano K, Yamamoto T, Endo F (2004) Flow cytometric isolation of endodermal progenitors from mouse salivary gland differentiate into hepatic and pancreatic lineages. Hepatology 39:667–675

    Article  PubMed  Google Scholar 

  25. Ahn JS, Camden JM, Schrader AM, Redman RS, Turner JT (2000) Reversible regulation of P2Y2 nucleotide receptor expression in the duct-ligated rat submandibular gland. Am J Physiol Cell Physiol 279:C286–C294

    CAS  PubMed  Google Scholar 

  26. Takahashi S, Shinzato K, Nakamura S, Domon T, Yamamoto T, Wakita M (2004) Cell death and cell proliferation in the regeneration of atrophied rat submandibular glands after duct ligation. J Oral Pathol Med 33:23–29

    Article  PubMed  Google Scholar 

  27. Denny PC, Chai Y, Klauser DK, Denny PA (1993) Parenchymal cell proliferation and mechanisms for maintenance of granular duct and acinar cell populations in adult male mouse submandibular gland. Anat Rec 235:475–485

    Article  CAS  PubMed  Google Scholar 

  28. Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, Okamoto H (1988) A novel gene activated in regenerating islets. J Biol Chem 263:2111–2114

    CAS  PubMed  Google Scholar 

  29. Okamoto H, Takasawa S (2002) Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in β-cells. Diabetes 51:S462–S473

    Article  CAS  PubMed  Google Scholar 

  30. Takasawa S (2016) Regenerating gene (REG) product and its potential clinical usage. Expert Opin Ther Targets 20:541–550

    Article  CAS  PubMed  Google Scholar 

  31. Zhang YW, Ding LS, Lai MD (2003) Reg gene family and human diseases. World J Gastroenterol 9:2635–2641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kazumori H, Ishihara S, Hoshino E, Kawashima K, Moriyama N, Suetsugu H, Sato H, Adachi K, Fukuda R, Watanabe M, Takasawa S, Okamoto H, Fukui H, Chiba T, Kinoshita Y (2000) Neutrophil chemoattractant 2β regulates expression of the Reg gene in injured gastric mucosa in rats. Gastroenterology 119:1610–1622

    Article  CAS  PubMed  Google Scholar 

  33. Planas R, Alba A, Carrillo J, Puertas MC, Ampudia R, Pastor X, Okamoto H, Takasawa S, Gurr W, Pujol-Borrell R, Verdaguer J, Vives-Pi M (2006) Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes; role of IFNβ. Diabetologia 49:2379–2387

    Article  CAS  PubMed  Google Scholar 

  34. Yoshino N, Ishihara S, Rumi MA, Ortega-Cava CF, Yuki T, Kazumori H, Takasawa S, Okamoto H, Kadowaki Y, Kinoshita Y (2005) Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected gastric mucosa. Am J Gastroenterol 100:2157–2166

    Article  CAS  PubMed  Google Scholar 

  35. Lee KS, Kalantzis A, Jackson CB, O’Connor L, Murata-Kamiya N, Hatakeyama M, Judd LM, Giraud AS, Menheniott TR (2012) Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation. PLoS One 7:e30786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Sekikawa A, Fukui H, Suzuki K, Karibe T, Fujii S, Ichikawa K, Tomita S, Imura J, Shiratori K, Chiba T, Fujimori T (2010) Involvement of the IL-22/REG Iα axis in ulcerative colitis. Lab Invest 90:496–505

    Article  CAS  PubMed  Google Scholar 

  37. Sekikawa A, Fukui H, Fujii S, Nanakin A, Kanda N, Uenoyama Y, Sawabu T, Hisatsune H, Kusaka T, Ueno S, Nakase H, Seno H, Fujimori T, Chiba T (2005) Possible role of REG Iα protein in ulcerative colitis and colitic cancer. Gut 54:1437–1444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Yoshimoto K, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Sakuramoto-Tsuchida S, Yamauchi A, Takeda M, Kasai T, Nakagawara K, Nonomura A, Takasawa S (2013) Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren’s syndrome. Clin Exp Immunol 174:1–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Foglia VG (1944) Charcteristicas de la diabetes en la rata. Revista de la Sociedad Argentina de Biologia 20:21–37

    CAS  Google Scholar 

  40. Martin JM, Lacy PE (1963) The prediabetic period in partially pancreatectomized rats. Diabetes 12:238–242

    Article  Google Scholar 

  41. Clark A, Bown E, King T, Vanhegan RI, Turner RC (1982) Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy. Diabetes 31:319–325

    Article  CAS  PubMed  Google Scholar 

  42. Watanabe T, Yonemura Y, Yonekura H, Suzuki Y, Miyashita H, Sugiyama K, Moriizumi S, Unno M, Tanaka O, Kondo H, Bone AJ, Takasawa S, Okamoto H (1994) Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 91:3589–3592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A, Slavin S (1998) Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 139:2369–2374

    Article  CAS  PubMed  Google Scholar 

  44. Shervani NJ, Takasawa S, Uchigata Y, Akiyama T, Nakagawa K, Noguchi N, Takada H, Takahashi I, Yamauchi A, Ikeda T, Iwamoto Y, Nata K, Okamoto H (2004) Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients. Eur J Clin Invest 34:752–758

    Article  CAS  PubMed  Google Scholar 

  45. Kobayashi S, Akiyama T, Nata K, Abe M, Tajima M, Shervani NJ, Unno M, Matsuno S, Sasaki H, Takasawa S, Okamoto H (2000) Identification of a receptor for Reg (Regenerating gene) protein, a pancreatic beta-cell regeneration factor. J Biol Chem 275:10723–10726

    Article  CAS  PubMed  Google Scholar 

  46. Acquatella-Tran Van Ba I, Marchal S, François F, Silhol M, Lleres C, Michel B, Benyamin Y, Verdier JM, Trousse F, Marcilhac A (2012) Regenerating islet-derived 1α (Reg-1α) protein is new neuronal secreted factor that stimulates neurite outgrowth via exostosin Tumor-like 3 (EXTL3) receptor. J Biol Chem 287:4726–4739

    Article  PubMed  CAS  Google Scholar 

  47. Kazumori H, Ishihara S, Fukuda R, Kinoshita Y (2002) Localization of Reg receptor in rat fundic mucosa. J Lab Clin Med 139:101–108

    Article  CAS  PubMed  Google Scholar 

  48. Kiji T, Dohi Y, Takasawa S, Okamoto H, Nonomura A, Taniguchi S (2005) Activation of regenerating gene Reg in rat and human hearts in response to acute stress. Am J Physiol Heart Circ Physiol 289:H277–H284

    Article  CAS  PubMed  Google Scholar 

  49. Bluth MH, Patel SA, Dieckgraefe BK, Okamoto H, Zenilman ME (2006) Pancreatic regenerating protein (reg I) and reg I receptor mRNA are upregulated in rat pancreas after induction of acute pancreatitis. World J Gastroenterol 12:4511–4516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Levetan CS, Upham LV, Deng S, Laury-Kleintop L, Kery V, Nolan R, Quinlan J, Torres C, El-Hajj RJ (2008) Discovery of a human peptide sequence signaling islet neogenesis. Endocr Panct 14:1075–1083

    Google Scholar 

  51. Hara K, Fukui H, Sun C, Kitayama Y, Eda H, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J, Fujimori T, Miwa H (2015) Effect of REG Iα protein on angiogenesis in gastric cancer tissues. Oncol Rep 33:2183–2189

    CAS  PubMed  Google Scholar 

  52. Takasawa S, Ikeda T, Akiyama T, Nata K, Nakagawa K, Shervani NJ, Noguchi N, Murakami-Kawaguchi S, Yamauchi A, Takahashi I, Tomioka-Kumagai T, Okamoto H (2006) Cyclin D1 activation through ATF-2 in Reg-induced pancreatic β-cell regeneration. FEBS Lett 580:585–591

    Article  CAS  PubMed  Google Scholar 

  53. Takahashi I, Noguchi N, Nata K, Yamada S, Kaneiwa T, Mizumoto S, Ikeda T, Sugihara K, Asano M, Yoshikawa T, Yamauchi A, Shervani NJ, Uruno A, Kato I, Unno M, Sugahara K, Takasawa S, Okamoto H, Sugawara A (2009) Important role of heparan sulfate in postnatal islet growth and insulin secretion. Biochem Biophys Res Commun 383:113–118

    Article  CAS  PubMed  Google Scholar 

  54. Nata K, Liu Y, Xu L, Ikeda T, Akiyama T, Noguchi N, Kawaguchi S, Yamauchi A, Takahashi I, Shervani NJ, Onogawa T, Takasawa S, Okamoto H (2004) Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III. Gene 340:161–170

    Article  CAS  PubMed  Google Scholar 

  55. Asahara M, Mushiake S, Shimada S, Fukui H, Kinoshita Y, Kawanami C, Watanabe T, Tanaka S, Ichikawa A, Uchiyama Y, Narushima Y, Takasawa S, Okamoto H, Tohyama M, Chiba T (1996) Reg gene expression is increased in rat gastric enterochromaffin-like cells following water immersion stress. Gastroenterology 111:45–55

    Article  CAS  PubMed  Google Scholar 

  56. Yamauchi A, Itaya-Hironaka A, Sakuramoto-Tsuchida S, Takeda M, Yoshimoto K, Miyaoka T, Fujimura T, Tsujinaka H, Tsuchida C, Ota H, Takasawa S (2015) Synergistic activations of REG Iα and REG Iβ promoters by IL-6 and glucocorticoids through JAK/STAT pathway in human pancreatic β cells. J Diabetes Res 2015:173058

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Hill T, Krougly O, Nikoopour E, Bellemore S, Lee-Chan E, Fouser LA, Hill DJ, Singh B (2013) The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes. Cell Regen (Lond) 2:2

    CAS  Google Scholar 

  58. Miyaoka Y, Kadowaki Y, Ishihara S, Ose T, Fukuhara H, Kazumori H, Takasawa S, Okamoto H, Chiba T, Kinoshita Y (2004) Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene 23:3572–3579

    Article  CAS  PubMed  Google Scholar 

  59. Yonemura Y, Sakurai S, Yamamoto H, Endou Y, Kawamura T, Bandou E, Elnemr A, Sugiyama K, Sasaki T, Akiyama T, Takasawa S, Okamoto H (2003) REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer 98:1394–1400

    Article  CAS  PubMed  Google Scholar 

  60. Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M, Nagasue N (2004) Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer 100:1130–1136

    Article  CAS  PubMed  Google Scholar 

  61. Macadam RC, Sarela AI, Farmery SM, Robinson PA, Markham AF, Guillou PJ (2000) Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer 83:188–195

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Harada K, Zen Y, Kanemori Y, Chen TC, Chen MF, Yeh TS, Jan YY, Masuda S, Nimura Y, Takasawa S, Okamoto H, Nakanuma Y (2001) Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions. Hepatology 33:1036–1042

    Article  CAS  PubMed  Google Scholar 

  63. Hayashi K, Motoyama S, Koyota S, Koizumi Y, Wang J, Takasawa S, Itaya-Hironaka A, Sakuramoto-Tsuchida S, Maruyama K, Saito H, Minamiya Y, Ogawa J, Sugiyama T (2008) REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci 99:2491–2495

    Article  CAS  PubMed  Google Scholar 

  64. Hayashi T, Matsubara A, Ohara S, Mita K, Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N, Yasui W (2009) Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker. Oncol Rep 21:95–100

    PubMed  Google Scholar 

  65. Masui T, Ota I, Itaya-Hironaka A, Takeda M, Kasai T, Yamauchi A, Sakuramoto-Tsuchida S, Mikami S, Yane K, Takasawa S, Hosoi H (2013) Expression of REG III and prognosis in head and neck cancer. Oncol Rep 30:573–578

    CAS  PubMed  Google Scholar 

  66. Kimura M, Naito H, Tojo T, Itaya-Hironaka A, Dohi Y, Yoshimura M, Nakagawara K, Takasawa S, Taniguchi S (2013) REG Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms. Oncol Rep 30:2625–2631

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Vives-Pi M, Takasawa S, Pujol-Autonell I, Planas R, Cabre E, Ojanguren I, Montraveta M, Santos AL, Ruiz-Ortiz E (2013) Biomarkers for diagnosis and monitoring of celiac disease. J Clin Gastroenterol 47:308–313

    Article  CAS  PubMed  Google Scholar 

  68. Kimura T, Fukui H, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, Fujii S, Imura J, Kawamata H, Chiba T, Imai Y, Fujimori T (2009) Involvement of REG Iα protein in the regeneration of ductal epithelial cells in the minor salivary glands of patients with Sjögren’s syndrome. Clin Exp Immunol 155:16–20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Ikehata F, Satoh J, Nata K, Tohgo A, Nakazawa T, Kato I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H (1998) Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin-dependent diabetes patients. J Clin Invest 102:395–401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Kohler PF, Winter ME (1985) A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 28:1128–1132

    Article  CAS  PubMed  Google Scholar 

  71. Azuma M, Sato M (1994) Morphogenesis of normal human salivary gland cells in vitro. Histol Histopathol 9:781–790

    CAS  PubMed  Google Scholar 

  72. Fujimura T, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Yoshimoto K, Yamauchi A, Sakuramoto-Tsuchida S, Kondo S, Takeda M, Tsujinaka H, Azuma M, Tanaka Y, Takasawa S (2015) Interleukin-6/STAT pathway is responsible for the induction of gene expression of REG Iα, a new auto-antigen in Sjögren’s syndrome patients, in salivary duct epithelial cells. Biochem Biophys Rep 2:69–74

    Google Scholar 

  73. Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H (1990) Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 265:7432–7439

    CAS  PubMed  Google Scholar 

  74. Zheng C, Baum BJ (2012) Including the p53 ELAV-like protein-binding site in vector cassettes enhances transgene expression in rat submandibular gland. Oral Dis 18:477–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Hoque AT, Liu X, Kagami H, Swaim WD, Wellner RB, O’Connell BC, Ambudkar IS, Baum BJ (2000) Construction and function of a recombinant adenovirus encoding a human aquaporin 1-green fluorescent protein fusion product. Cancer Gene Ther 7:476–485

    Article  CAS  PubMed  Google Scholar 

  76. Fujimoto T, Yoshimoto K, Fujimura T, Takeda M, Itaya-Hironaka A, Takasawa S (2014) New aspects of mechanism of salivary gland dysfunction in Sjögren’s syndrome. In: Hernandez EM (ed) Sjögren’s syndrome: symptoms, treatment options and potential health complications. Nova Scientific Publishers, Inc., New York, pp 125–158

    Google Scholar 

  77. Van Belle TL, Pagni PP, Liao J, Sachithanantham S, Dave A, Bel Hani A, Manenkova Y, Amirian N, Yang C, Morin B, Zhang H, Campbell IL, von Herrath MG (2014) Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes. J Autoimmun 55:24–32

    Article  PubMed  CAS  Google Scholar 

  78. Zhang C, Zhang X, Chen XH (2014) Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance. Clin Rev Allergy Immunol 47:163–173

    Article  CAS  PubMed  Google Scholar 

  79. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40:656–661

    Article  CAS  Google Scholar 

  80. Szodoray P, Alex P, Brun JG, Centola M, Jonsson R (2004) Circulating cytokines in primary Sjögren’s syndrome determined by a multiplex cytokine array system. Scand J Immunol 59:592–599

    Article  CAS  PubMed  Google Scholar 

  81. Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548–2556

    Article  CAS  PubMed  Google Scholar 

  82. Bromberg J (2002) Stat proteins and oncogenesis. J Clin Invest 109:1139–1142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD (2000) Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 97:4227–4232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Song JI, Grandis JR (2000) STAT signaling in head and neck cancer. Oncogene 19:2489–2495

    Article  CAS  PubMed  Google Scholar 

  85. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ (2002) Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21:8404–8413

    Article  CAS  PubMed  Google Scholar 

  86. Ghoreschi K, Laurence A, O’Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273–287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Liu X, Wang J, Wang H, Yin G, Liu Y, Lei X, Xiang M (2015) REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: involvement of a REG3A-JAK2/STAT3 positive feedback loop. Cancer Lett 362:45–60

    Article  CAS  PubMed  Google Scholar 

  88. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T, Fujimori T (2008) REG Iα protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 29:76–83

    Article  CAS  PubMed  Google Scholar 

  89. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741

    Article  CAS  PubMed  Google Scholar 

  90. Cuello C, Palladinetti P, Tedla N, Di Girolamo N, Lloyd AR, McCluskey PJ, Wakefield D (1998) Chemokine expression and leucocyte infiltration in Sjögren’s syndrome. Br J Rheumatol 37:779–783

    Article  CAS  PubMed  Google Scholar 

  91. Ota H, Itaya-Hironaka A, Yamauchi A, Sakuramoto-Tsuchida S, Miyaoka T, Fujimura T, Tsujinaka H, Yoshimoto K, Nakagawara K, Tamaki S, Takasawa S, Kimura H (2013) Pancreatic β cell proliferation by intermittent hypoxia via up-regulation of Reg family genes and HGF gene. Life Sci 93:664–672

    Article  CAS  PubMed  Google Scholar 

  92. Unno M, Nata K, Noguchi N, Narushima Y, Akiyama T, Ikeda T, Nakagawa K, Takasawa S, Okamoto H (2002) Production and characterization of Reg knockout mice: reduced proliferation of pancreatic β-cells in Reg knockout mice. Diabetes 51:S478-S483

    Article  CAS  PubMed  Google Scholar 

  93. Reksten TR, Brokstad KA, Jonsson R, Brun JG, Jonsson MV (2011) Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren’s syndrome. Int Immunopharmacol 11:2125–2129

    Article  CAS  PubMed  Google Scholar 

  94. Price EJ, Rigby SP, Clancy U, Venables PJ (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren’s syndrome. J Rheumatol 25:896–899

    CAS  PubMed  Google Scholar 

  95. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM (1996) Methotrexate in primary Sjögren’s syndrome. Clin Exp Rheumatol 14:555–558

    CAS  PubMed  Google Scholar 

  96. Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minota S, Nara H, Kondo H, Okada J, Mimori T, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y (2007) Efficacy and safety of mizoribine for the treatment of Sjögren’s syndrome: a multicenter open-label clinical trial. Mod Rheumatol 17:464–469

    Article  CAS  PubMed  Google Scholar 

  97. Mócsai A, Kovács L, Gergely P (2014) What is the future of targeted therapy in rheumatology: biologics or small molecules. BMC Med 12:43

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Cornec D, Jamin C, Pers JO (2014) Sjögren’s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–14

    Article  PubMed  Google Scholar 

  99. Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960–968

    Article  CAS  PubMed  Google Scholar 

  100. Carubbi F, Cipriani P, Marreli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R (2013) Efficacy and safety of rituximab treatment in early primary Sjögren’s syndrome: a prospective, multi-center, follow-up study. Arthritis Res Ther 15:R172

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Váncsa A, Szabó Z, Szamosi S, Bodnár N, Végh E, Gergely L, Szucs G, Szántó S, Szekanecz Z (2013) Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion. J Rheumatol 40:565–571

    Article  PubMed  CAS  Google Scholar 

  102. Yamauchi A, Takahashi I, Takasawa S, Nata K, Noguchi N, Ikeda T, Yoshikawa T, Shervani NJ, Suzuki I, Uruno A, Unno M, Okamoto H, Sugawara A (2009) Thiazolidinediones inhibit REG Iα gene transcription in gastrointestinal cancer cells. Biochem Biophys Res Commun 379:743–748

    Article  CAS  PubMed  Google Scholar 

  103. Takasawa S, Kuroki M, Nata K, Noguchi N, Ikeda T, Yamauchi A, Ota H, Itaya-Hironaka A, Sakuramoto-Tsuchida S, Takahashi I, Yoshikawa T, Shimosegawa T, Okamoto H (2010) A novel ryanodine receptor expressed in pancreatic islets by alternative splicing from type 2 ryanodine receptor gene. Biochem Biophys Res Commun 397:140–145

    Article  CAS  PubMed  Google Scholar 

  104. Ota H, Tamaki S, Itaya-Hironaka A, Yamauchi A, Sakuramoto-Tsuchida S, Morioka T, Takasawa S, Kimura H (2012) Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38. Life Sci 90:206–211

    Article  CAS  PubMed  Google Scholar 

  105. Nakagawa K, Takasawa S, Nata K, Yamauchi A, Itaya-Hironaka A, Ota H, Yoshimoto K, Sakuramoto-Tsuchida S, Miyaoka T, Takeda M, Unno M, Okamoto H (2013) Prevention of Reg I-induced β-cell apoptosis by IL-6/dexamethasone through activation of HGF gene regulation. Biochim Biophys Acta 1833:2988–2995

    Article  CAS  PubMed  Google Scholar 

  106. Tsujinaka H, Itaya-Hironaka A, Yamauchi A, Sakuramoto-Tsuchida S, Ota H, Takeda M, Fujimura T, Takasawa S, Ogata N (2015) Human retinal pigment epithelial cell proliferation by the combined stimulation of hydroquinone and advanced glycation end-products via up-regulation of VEGF gene. Biochem Biophys Rep 2:123–131

    Google Scholar 

Download references

Acknowledgments

The authors are grateful to Dr. Masayuki Azuma from the Tokushima University School of Dentistry for providing NS-SV-DC human salivary ductal cells and Dr. Bruce J. Baum from the National Institute of Dental and Craniofacial Research, NIH for providing A5 rat salivary ductal cells. We are also grateful to Drs. Shinobu Nakamura and Yoshiko Dohi from the Nara Medical University for encouragement. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and Japan Science and Technology Agency.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shin Takasawa.

Ethics declarations

Conflict of Interest

Takanori Fujimura, Takashi Fujimoto, Asako Itaya-Hironaka, Tomoko Miyaoka, Kiyomi Yoshimoto, Sumiyo Sakuramoto-Tsuchida, Akiyo Yamauchi, Maiko Takeda, Hiroki Tsujinaka, Yasuhito Tanaka, and Shin Takasawa declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujimura, T., Fujimoto, T., Itaya-Hironaka, A. et al. Significance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren’s Syndrome Patients, in Salivary Duct Epithelial Cells. Clinic Rev Allerg Immunol 52, 351–363 (2017). https://doi.org/10.1007/s12016-016-8570-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-016-8570-7

Keywords

Navigation